Skip to main content

Scynexis Inc

SCYX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001178253

No open-market purchases or sales by Scynexis Inc insiders were filed in the last 90 days; 40 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Scynexis Inc changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of SCYX: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders4146+5
Shares10.2M15.0M+4.85M (+47.6%)
Value$54.1M$91.7M+$37.6M (+69.5%)

New holders (11)

Institutions that held Scynexis Inc at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to SCYX in Q4 2021
InstitutionSharesValue% of portfolio
DAFNA Capital Management LLC121,242$740.0K0.19%
Wealth Effects LLC87,800$536.0K0.22%
Empery Asset Management, LP43,294$264.0K0.55%
Chicago Partners Investment Group LLC41,675$189.0K0.01%
Simplex Trading, LLC2,649$16.0K0.00%
Tower Research Capital LLC (TRC)2,102$13.0K0.00%
Signet Financial Management, LLC1,680$10.0K0.00%
Larson Financial Group LLC800$5.00K0.00%
CWM, LLC660$4.00K0.00%
Cutler Group LP250$1.00K0.00%
Beaird Harris Wealth Management, LLC126$1.00K0.00%

Sold out (6)

Institutions that held Scynexis Inc at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of SCYX in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Scion Asset Management, LLC174,030$922.0K
Gsa Capital Partners LLP89,834$476.0K
Altium Capital Management LP70,000$371.0K
Two Sigma Investments, LP68,980$366.0K
Stonepine Capital Management, LLC6,327$34.0K
Capital Advisors, Ltd. LLC900$5.00K